Skip to main content
Erschienen in: Journal of Cancer Survivorship 4/2014

01.12.2014

Associations among survivorship care plans, experiences of survivorship care, and functioning in older breast cancer survivors: CALGB/Alliance 369901

verfasst von: Leigh Anne Faul, Gheorghe Luta, Vanessa Sheppard, Claudine Isaacs, Harvey J. Cohen, Hyman B. Muss, Rachel Yung, Jonathan D. Clapp, Eric Winer, Clifford Hudis, Michelle Tallarico, Julhy Wang, William T. Barry, Jeanne S. Mandelblatt

Erschienen in: Journal of Cancer Survivorship | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Survivorship care plans (SCP) are recommended for all cancer patients and could be especially useful to survivors 65 years and over (“older”). This study examined receipt of SCPs among older breast cancer survivors and whether SCPs were associated with improved patient-reported outcomes.

Methods

Three hundred and twenty-eight older women diagnosed with invasive, nonmetastatic breast cancer between 2007–2011 were recruited from 78 cooperative-group sites. Participants completed telephone interviews at baseline and 1-year posttreatment. Regression analyses examined SCP receipt (yes/no) and functioning (EORTC-QLQ-C30), cancer worry, and experiences of survivorship care (care coordination, knowledge).

Results

Only 35 % of women received SCPs. For each 1-year increase in age, there was a 5 % lower odds of receiving an SCP (odds ratio (OR) = 0.94, 95 % confidence interval (CI) 0.91–0.98, p = 0.007). Besides age, no other factor predicted SCPs. SCP receipt was associated with greater knowledge and understanding of requisite follow-up care (p < 0.05); however, functioning was not significantly different among those with vs. without SCPs.

Conclusions

Receipt of care plans was limited. SCPs improved understanding of breast cancer follow-up care among older survivors, but did not impact functioning one year post-treatment.

Implications for Cancer Survivors

To impact functioning and salient needs of the growing cohort of older survivors, survivorship care plans likely should be tailored to geriatric-specific issues. To improve functioning, SCP content should expand to include exercise, nutrition, polypharmacy, social support and management of symptom burden from cancer, and other comorbid conditions. To improve follow-up care for cancer survivors, SCPs should delineate shared care roles between oncology and primary care in managing recurrence surveillance, screening, and cancer sequelae.
Literatur
2.
Zurück zum Zitat Parry C, Kent EE, Mariotto AB, Alfano CM, Rowland JH. Cancer survivors: a booming population. Cancer Epidemiol Biomarkers Prev. 2011;20:1996–2005.PubMedCentralCrossRefPubMed Parry C, Kent EE, Mariotto AB, Alfano CM, Rowland JH. Cancer survivors: a booming population. Cancer Epidemiol Biomarkers Prev. 2011;20:1996–2005.PubMedCentralCrossRefPubMed
3.
Zurück zum Zitat Hanchate AD, Clough-Gorr KM, Ash AS, Thwin SS, Silliman RA. Longitudinal patterns in survival, comorbidity, healthcare utilization and quality of care among older women following breast cancer diagnosis. J Gen Intern Med. 2010;25:1045–50.PubMedCentralCrossRefPubMed Hanchate AD, Clough-Gorr KM, Ash AS, Thwin SS, Silliman RA. Longitudinal patterns in survival, comorbidity, healthcare utilization and quality of care among older women following breast cancer diagnosis. J Gen Intern Med. 2010;25:1045–50.PubMedCentralCrossRefPubMed
4.
Zurück zum Zitat Clough-Gorr KM, Stuck AE, Thwin SS, Silliman RA. Older breast cancer survivors: geriatric assessment domains are associated with poor tolerance of treatment adverse effects and predict mortality over 7 years of follow-up. J Clin Oncol. 2010;28:380–6.PubMedCentralCrossRefPubMed Clough-Gorr KM, Stuck AE, Thwin SS, Silliman RA. Older breast cancer survivors: geriatric assessment domains are associated with poor tolerance of treatment adverse effects and predict mortality over 7 years of follow-up. J Clin Oncol. 2010;28:380–6.PubMedCentralCrossRefPubMed
5.
Zurück zum Zitat Mohile SG, Fan L, Reeve E, Jean-Pierre P, Mustian K, Peppone L, et al. Association of cancer with geriatric syndromes in older Medicare beneficiaries. J Clin Oncol. 2011;29:1458–64.PubMedCentralCrossRefPubMed Mohile SG, Fan L, Reeve E, Jean-Pierre P, Mustian K, Peppone L, et al. Association of cancer with geriatric syndromes in older Medicare beneficiaries. J Clin Oncol. 2011;29:1458–64.PubMedCentralCrossRefPubMed
6.
Zurück zum Zitat Yabroff KR, Lawrence W, Clauser S, Davis W, Martin ML. Burden of illness in cancer survivors: findings from a population-based national sample. J Natl Cancer Inst. 2004;96:1322–30.CrossRefPubMed Yabroff KR, Lawrence W, Clauser S, Davis W, Martin ML. Burden of illness in cancer survivors: findings from a population-based national sample. J Natl Cancer Inst. 2004;96:1322–30.CrossRefPubMed
7.
Zurück zum Zitat Edwards BK, Howe HL, Ries LAG, Thun MJ, Rosenberg HM, Yancik R, et al. Annual report to the nation on the status of cancer, 1973–1999, featuring implications of age and aging on U.S. cancer burden. Cancer. 2002;94:2766–92.CrossRefPubMed Edwards BK, Howe HL, Ries LAG, Thun MJ, Rosenberg HM, Yancik R, et al. Annual report to the nation on the status of cancer, 1973–1999, featuring implications of age and aging on U.S. cancer burden. Cancer. 2002;94:2766–92.CrossRefPubMed
8.
Zurück zum Zitat Royak-Schaler R, Gardner LD, Shardell M, Zhan M, Passmore SR, Gadalla SM, et al. Evidence-based care for breast cancer survivors: communicating the Institute of Medicine Guidelines in medical practice. Patient Educ Couns. 2009;77:413–20.CrossRefPubMed Royak-Schaler R, Gardner LD, Shardell M, Zhan M, Passmore SR, Gadalla SM, et al. Evidence-based care for breast cancer survivors: communicating the Institute of Medicine Guidelines in medical practice. Patient Educ Couns. 2009;77:413–20.CrossRefPubMed
9.
Zurück zum Zitat Earle CC, Burstein H, Winer, Weeks JC. Quality of non-breast cancer health maintenance among elderly breast cancer survivors. J Clin Oncol. 2003;21:1447–51.CrossRefPubMed Earle CC, Burstein H, Winer, Weeks JC. Quality of non-breast cancer health maintenance among elderly breast cancer survivors. J Clin Oncol. 2003;21:1447–51.CrossRefPubMed
10.
Zurück zum Zitat Cheung W, Neville B, Earle CC. Associations among cancer survivorship discussions, patient and physician expectations, and receipt of follow-up care. J Clin Oncol. 2010;28:2577–83.CrossRefPubMed Cheung W, Neville B, Earle CC. Associations among cancer survivorship discussions, patient and physician expectations, and receipt of follow-up care. J Clin Oncol. 2010;28:2577–83.CrossRefPubMed
11.
Zurück zum Zitat Nissen MJ, Tsai ML, Blaes AH, Swenson KK. Breast and colorectal cancer survivors’ knowledge about their diagnosis and treatment. J Cancer Surviv. 2010;6:20–32.CrossRef Nissen MJ, Tsai ML, Blaes AH, Swenson KK. Breast and colorectal cancer survivors’ knowledge about their diagnosis and treatment. J Cancer Surviv. 2010;6:20–32.CrossRef
12.
Zurück zum Zitat Forsythe LP, Alfano CM, Leach CR, Ganz PA, Stefanek ME, Rowland JH. Who provides psychosocial follow-up care for post-treatment cancer survivors? A survey of medical oncologists and primary care physicians. J Clin Oncol. 2012;30:2897–905.PubMedCentralCrossRefPubMed Forsythe LP, Alfano CM, Leach CR, Ganz PA, Stefanek ME, Rowland JH. Who provides psychosocial follow-up care for post-treatment cancer survivors? A survey of medical oncologists and primary care physicians. J Clin Oncol. 2012;30:2897–905.PubMedCentralCrossRefPubMed
13.
Zurück zum Zitat Beckjord EB, Arora NK, McLaughlin W, Oakley-Girvan I, Hamilton AS, Hesse BW. Health-related information needs in a large and diverse sample of adult cancer survivors: implications for cancer care. J Cancer Surviv. 2008;2:179–89.CrossRefPubMed Beckjord EB, Arora NK, McLaughlin W, Oakley-Girvan I, Hamilton AS, Hesse BW. Health-related information needs in a large and diverse sample of adult cancer survivors: implications for cancer care. J Cancer Surviv. 2008;2:179–89.CrossRefPubMed
14.
Zurück zum Zitat Yeom HE. Symptoms, aging-stereotyped beliefs, and health-promoting behaviors of older women with and without osteoarthritis. Geriatr Nurs. 2013;34:307–13.CrossRefPubMed Yeom HE. Symptoms, aging-stereotyped beliefs, and health-promoting behaviors of older women with and without osteoarthritis. Geriatr Nurs. 2013;34:307–13.CrossRefPubMed
15.
Zurück zum Zitat Sarkisian CA, Hays RD, Berry SH, Mangione CM. Expectations regarding aging among older adults and physicians who care for older adults. Med Care. 2001;39:1025–36.CrossRefPubMed Sarkisian CA, Hays RD, Berry SH, Mangione CM. Expectations regarding aging among older adults and physicians who care for older adults. Med Care. 2001;39:1025–36.CrossRefPubMed
16.
Zurück zum Zitat Oladimeji O, Farris KB, Urmie JG, Doucette WR. Symptomatology, attribution to medicines, and symptom reporting among Medicare enrollees. Res Social Adm Pharm. 2009;5:225–33.CrossRefPubMed Oladimeji O, Farris KB, Urmie JG, Doucette WR. Symptomatology, attribution to medicines, and symptom reporting among Medicare enrollees. Res Social Adm Pharm. 2009;5:225–33.CrossRefPubMed
17.
Zurück zum Zitat Sarkisian CA, Hays RD, Mangione CM. Do older adults expect to age successfully? The association between expectations regarding aging and beliefs regarding healthcare seeking among older adults. J Am Geriatr Soc. 2002;50:1837–43.CrossRefPubMed Sarkisian CA, Hays RD, Mangione CM. Do older adults expect to age successfully? The association between expectations regarding aging and beliefs regarding healthcare seeking among older adults. J Am Geriatr Soc. 2002;50:1837–43.CrossRefPubMed
18.
Zurück zum Zitat Hewitt M, Greefield S, Stovall E. From cancer patient to cancer survivor: lost in transition. Washington, DC: National Acadamies Press; 2005. Hewitt M, Greefield S, Stovall E. From cancer patient to cancer survivor: lost in transition. Washington, DC: National Acadamies Press; 2005.
19.
Zurück zum Zitat National Coalition for Cancer Survivorship. Institute of Medicine and National Cancer Policy Forum, Implementing Cancer Survivorship Care Planning.(workshop summary). Washington: National Academies Press; 2007. National Coalition for Cancer Survivorship. Institute of Medicine and National Cancer Policy Forum, Implementing Cancer Survivorship Care Planning.(workshop summary). Washington: National Academies Press; 2007.
24.
Zurück zum Zitat Ganz PA, Hahn EE. Implementing a survivorship care plan for patients with breast cancer. J Clin Oncol. 2008;26:759–67.CrossRefPubMed Ganz PA, Hahn EE. Implementing a survivorship care plan for patients with breast cancer. J Clin Oncol. 2008;26:759–67.CrossRefPubMed
25.
Zurück zum Zitat Siegel RD, Clauser SB, Lynn JM. National Collaborative to Improve Oncology Practice: The National Cancer Institute Community Cancer Centers Program Quality Oncology Practice Initiative Experience. J Oncol Pract. 2009;5:276–81.PubMedCentralCrossRefPubMed Siegel RD, Clauser SB, Lynn JM. National Collaborative to Improve Oncology Practice: The National Cancer Institute Community Cancer Centers Program Quality Oncology Practice Initiative Experience. J Oncol Pract. 2009;5:276–81.PubMedCentralCrossRefPubMed
26.
Zurück zum Zitat Forsythe LP, Parry C, Alfano CM, Kent EE, Leach CR, Haggstrom DA, et al. Use of survivorship care plans in the United States: associations with survivorship care. J Natl Cancer Inst. 2013;105:1579–87.PubMedCentralCrossRefPubMed Forsythe LP, Parry C, Alfano CM, Kent EE, Leach CR, Haggstrom DA, et al. Use of survivorship care plans in the United States: associations with survivorship care. J Natl Cancer Inst. 2013;105:1579–87.PubMedCentralCrossRefPubMed
27.
Zurück zum Zitat Stricker CT, Jacobs LA, Risendal B, Jones A, Panzer S, Ganz PA. Survivorship care planning after the Institute of Medicine recommendations: how are we faring? J Cancer Surviv. 2011;5:358–70.CrossRefPubMed Stricker CT, Jacobs LA, Risendal B, Jones A, Panzer S, Ganz PA. Survivorship care planning after the Institute of Medicine recommendations: how are we faring? J Cancer Surviv. 2011;5:358–70.CrossRefPubMed
28.
Zurück zum Zitat Sabatino SA, Thompson TD, Smith JL, Rowland JH, Forsythe LP, Pollack L, et al. Receipt of cancer treatment summaries and follow-up instructions among adult cancer survivors: results from a national survey. J Cancer Surviv. 2013;7:32–43.CrossRefPubMed Sabatino SA, Thompson TD, Smith JL, Rowland JH, Forsythe LP, Pollack L, et al. Receipt of cancer treatment summaries and follow-up instructions among adult cancer survivors: results from a national survey. J Cancer Surviv. 2013;7:32–43.CrossRefPubMed
29.
Zurück zum Zitat Hershman DL, Greenlee H, Awad D, Kalinsky K, Maurer M, Kranwinkel G, et al. Randomized controlled trial of a clinic-based survivorship intervention following adjuvant therapy in breast cancer survivors. Breast Cancer Res Treat. 2013;138:795–806.CrossRefPubMed Hershman DL, Greenlee H, Awad D, Kalinsky K, Maurer M, Kranwinkel G, et al. Randomized controlled trial of a clinic-based survivorship intervention following adjuvant therapy in breast cancer survivors. Breast Cancer Res Treat. 2013;138:795–806.CrossRefPubMed
30.
Zurück zum Zitat Grunfeld E, Julian JA, Pond G, Maunsell E, Coyle D, Folkes A, et al. Evaluating survivorship care plans: results of a randomized, clinical trial of patients with breast cancer. J Clin Oncol. 2011;29:4755–62.CrossRefPubMed Grunfeld E, Julian JA, Pond G, Maunsell E, Coyle D, Folkes A, et al. Evaluating survivorship care plans: results of a randomized, clinical trial of patients with breast cancer. J Clin Oncol. 2011;29:4755–62.CrossRefPubMed
31.
Zurück zum Zitat Faul LA, Rivers B, Shibata D, Townsend I, Meredith K, Cabrera P. Survivorship care planning in colorectal cancer: feedback from survivors and providers. J Psychosoc Oncol. 2012;30:198–216.PubMedCentralCrossRefPubMed Faul LA, Rivers B, Shibata D, Townsend I, Meredith K, Cabrera P. Survivorship care planning in colorectal cancer: feedback from survivors and providers. J Psychosoc Oncol. 2012;30:198–216.PubMedCentralCrossRefPubMed
32.
Zurück zum Zitat Oeffinger KC, Hudson MM, Mertens AC, Smith SM, Mitby PA, Eshelman-Kent DA, et al. Increasing rates of breast cancer and cardiac surveillance among high-risk survivors of childhood Hodgkin lymphoma following a mailed, one-page survivorship care plan. Pediatr Blood Cancer. 2011;56:818–24.PubMedCentralCrossRefPubMed Oeffinger KC, Hudson MM, Mertens AC, Smith SM, Mitby PA, Eshelman-Kent DA, et al. Increasing rates of breast cancer and cardiac surveillance among high-risk survivors of childhood Hodgkin lymphoma following a mailed, one-page survivorship care plan. Pediatr Blood Cancer. 2011;56:818–24.PubMedCentralCrossRefPubMed
33.
Zurück zum Zitat Parry C, Kent EE, Forsythe LP, Alfano CM, Rowland JH. Can't see the forest for the care plan: a call to revisit the context of care planning. J Clin Oncol. 2013;31:2651–3.PubMedCentralCrossRefPubMed Parry C, Kent EE, Forsythe LP, Alfano CM, Rowland JH. Can't see the forest for the care plan: a call to revisit the context of care planning. J Clin Oncol. 2013;31:2651–3.PubMedCentralCrossRefPubMed
34.
Zurück zum Zitat Cohen HJ. Functional assessment and the cancer survivor: something old, something new. J Natl Cancer Inst. 2010;102:1450–1.CrossRefPubMed Cohen HJ. Functional assessment and the cancer survivor: something old, something new. J Natl Cancer Inst. 2010;102:1450–1.CrossRefPubMed
35.
Zurück zum Zitat Mandelblatt JS, Sheppard VB, Hurria A, Kimmick G, Isaacs C, Taylor KL, et al. Breast cancer adjuvant chemotherapy decisions in older women: the role of patient preference and interactions with physicians. J Clin Oncol. 2010;28:3146–53.PubMedCentralCrossRefPubMed Mandelblatt JS, Sheppard VB, Hurria A, Kimmick G, Isaacs C, Taylor KL, et al. Breast cancer adjuvant chemotherapy decisions in older women: the role of patient preference and interactions with physicians. J Clin Oncol. 2010;28:3146–53.PubMedCentralCrossRefPubMed
36.
Zurück zum Zitat Mandelblatt JS, Faul LA, Luta G, Makgoeng SB, Isaacs C, Taylor K, et al. Patient and physician decision styles and breast cancer chemotherapy use in older women: Cancer and Leukemia Group B protocol 369901. J Clin Oncol. 2012;30:2609–14.PubMedCentralCrossRefPubMed Mandelblatt JS, Faul LA, Luta G, Makgoeng SB, Isaacs C, Taylor K, et al. Patient and physician decision styles and breast cancer chemotherapy use in older women: Cancer and Leukemia Group B protocol 369901. J Clin Oncol. 2012;30:2609–14.PubMedCentralCrossRefPubMed
37.
Zurück zum Zitat Katzman R, Brown T, Fuld P, Peck A, Schechter R, Schimmel H. Validation of a short orientation-memory-concentration test of cognitive impairment. Am J Psychiatry. 1983;140:734–9.CrossRefPubMed Katzman R, Brown T, Fuld P, Peck A, Schechter R, Schimmel H. Validation of a short orientation-memory-concentration test of cognitive impairment. Am J Psychiatry. 1983;140:734–9.CrossRefPubMed
38.
Zurück zum Zitat Safran DG, Kosinski M, Tarlov AR, Rogers WH, Taira DH, Lieberman N, et al. The primary care assessment survey: tests of data quality and measurement performance. Med Care. 1998;36:728–39.CrossRefPubMed Safran DG, Kosinski M, Tarlov AR, Rogers WH, Taira DH, Lieberman N, et al. The primary care assessment survey: tests of data quality and measurement performance. Med Care. 1998;36:728–39.CrossRefPubMed
39.
Zurück zum Zitat Maly RC, Frank JC, Marshall GN, DiMatteo MR, Reuben DB. Perceived efficacy in patient-physician interactions (PEPPI): validation of an instrument in older persons. J Am Geriatr Soc. 1998;46:889–94.CrossRefPubMed Maly RC, Frank JC, Marshall GN, DiMatteo MR, Reuben DB. Perceived efficacy in patient-physician interactions (PEPPI): validation of an instrument in older persons. J Am Geriatr Soc. 1998;46:889–94.CrossRefPubMed
40.
Zurück zum Zitat Cleary PD, Edgman-Levitan S, Roberts M, Moloney TW, McMullen W, Walker JD, et al. Patients evaluate their hospital care: a national survey. Health Aff(Millwood). 1991;10:254–67. Cleary PD, Edgman-Levitan S, Roberts M, Moloney TW, McMullen W, Walker JD, et al. Patients evaluate their hospital care: a national survey. Health Aff(Millwood). 1991;10:254–67.
41.
Zurück zum Zitat Gerteis M, Edgman-Levitan S, Daley J, Delblanco T. Through the patient's eyes. San Franscisco: Jossey-Bass; 1993. Gerteis M, Edgman-Levitan S, Daley J, Delblanco T. Through the patient's eyes. San Franscisco: Jossey-Bass; 1993.
42.
Zurück zum Zitat Arora NK, Reeve BB, Hays RD, Clauser SB, Oakley-Girvan I. Assessment of quality of cancer-related follow-up care from the cancer survivor's perspective. J Clin Oncol. 2011;29:1280–9.PubMedCentralCrossRefPubMed Arora NK, Reeve BB, Hays RD, Clauser SB, Oakley-Girvan I. Assessment of quality of cancer-related follow-up care from the cancer survivor's perspective. J Clin Oncol. 2011;29:1280–9.PubMedCentralCrossRefPubMed
43.
Zurück zum Zitat Teno JM, Lima JC, Lyons KD. Cancer patient assessment and reports of excellence: reliability and validity of advanced cancer patient perceptions of the quality of care. J Clin Oncol. 2009;27:1621–6.PubMedCentralCrossRefPubMed Teno JM, Lima JC, Lyons KD. Cancer patient assessment and reports of excellence: reliability and validity of advanced cancer patient perceptions of the quality of care. J Clin Oncol. 2009;27:1621–6.PubMedCentralCrossRefPubMed
44.
Zurück zum Zitat Coulter A, Cleary PD. Patients’ experiences with hospital care in five countries. Health Aff(Millwood). 2001;20:244–52. Coulter A, Cleary PD. Patients’ experiences with hospital care in five countries. Health Aff(Millwood). 2001;20:244–52.
45.
Zurück zum Zitat Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–76.CrossRefPubMed Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–76.CrossRefPubMed
46.
Zurück zum Zitat Sprangers MA, Groenvold M, Arraras JI, Franklin J, et al. The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol. 1996;14:2756–68.PubMed Sprangers MA, Groenvold M, Arraras JI, Franklin J, et al. The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol. 1996;14:2756–68.PubMed
48.
Zurück zum Zitat Hjermstad M, Fossa S, Bjordal K, Kaasa S. Test-retest of the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire. J Clin Oncol. 1995;13:1249–54.PubMed Hjermstad M, Fossa S, Bjordal K, Kaasa S. Test-retest of the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire. J Clin Oncol. 1995;13:1249–54.PubMed
49.
Zurück zum Zitat Hjermstad M, Fayers P, Bjordal K, Kaasa S. Using reference data on quality of life: the importance of adjusting for age and gender, exemplified by the EORTC QLQ-C30 (+3). J Clin Oncol. 1998;34:1381–9.CrossRef Hjermstad M, Fayers P, Bjordal K, Kaasa S. Using reference data on quality of life: the importance of adjusting for age and gender, exemplified by the EORTC QLQ-C30 (+3). J Clin Oncol. 1998;34:1381–9.CrossRef
50.
Zurück zum Zitat Ganz PA, Schag CA, Lee JJ, Sim MS, The CARES. A generic measure of health-related quality of life for patients with cancer. Qual Life Res. 1992;1:19–29.CrossRefPubMed Ganz PA, Schag CA, Lee JJ, Sim MS, The CARES. A generic measure of health-related quality of life for patients with cancer. Qual Life Res. 1992;1:19–29.CrossRefPubMed
51.
Zurück zum Zitat Fillenbaum GG, Smyer MA. The development, validity, and reliability of the OARS multidimensional functional assessment questionnaire. J Gerontol. 1981;36:428–34.CrossRefPubMed Fillenbaum GG, Smyer MA. The development, validity, and reliability of the OARS multidimensional functional assessment questionnaire. J Gerontol. 1981;36:428–34.CrossRefPubMed
52.
Zurück zum Zitat Ware J, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220–33.CrossRefPubMed Ware J, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220–33.CrossRefPubMed
53.
Zurück zum Zitat Gandek B, Ware JE, Aaronson NK, Apolone G, Bjorner JB, Brazier JE, et al. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: Results from the IQOLA Project. J Clin Epidemiol. 1998;51:1171–8.CrossRefPubMed Gandek B, Ware JE, Aaronson NK, Apolone G, Bjorner JB, Brazier JE, et al. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: Results from the IQOLA Project. J Clin Epidemiol. 1998;51:1171–8.CrossRefPubMed
54.
Zurück zum Zitat Osoba D, Rodrigues G, Myles J, Zee B, Pater J. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol. 1998;16:139–44.PubMed Osoba D, Rodrigues G, Myles J, Zee B, Pater J. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol. 1998;16:139–44.PubMed
55.
Zurück zum Zitat Cohen HJ, Lan L, Archer L, Kornblith AB. Impact of age, comorbidity and symptoms on physical function in long-term breast cancer survivors (CALGB 70803). J Geriatr Oncol. 2012;3:82–9.PubMedCentralCrossRefPubMed Cohen HJ, Lan L, Archer L, Kornblith AB. Impact of age, comorbidity and symptoms on physical function in long-term breast cancer survivors (CALGB 70803). J Geriatr Oncol. 2012;3:82–9.PubMedCentralCrossRefPubMed
56.
Zurück zum Zitat Chavez-Macgregor M, Zhang N, Buchholz TA, Zhang Y, Niu J, Elting L, et al. Trastuzumab-related cardiotoxicity among older patients with breast cancer. J Clin Oncol. 2013;31:4222–8.PubMedCentralCrossRefPubMed Chavez-Macgregor M, Zhang N, Buchholz TA, Zhang Y, Niu J, Elting L, et al. Trastuzumab-related cardiotoxicity among older patients with breast cancer. J Clin Oncol. 2013;31:4222–8.PubMedCentralCrossRefPubMed
57.
58.
Zurück zum Zitat Coyle D, Grunfeld E, Coyle K, Pond G, Julian J, Levine M. Cost effectiveness of a survivorship care plan for breast cancer survivors. J Oncol Pract. 2014;10:e86–92.CrossRefPubMed Coyle D, Grunfeld E, Coyle K, Pond G, Julian J, Levine M. Cost effectiveness of a survivorship care plan for breast cancer survivors. J Oncol Pract. 2014;10:e86–92.CrossRefPubMed
59.
Zurück zum Zitat Griggs J, Sorbero M, Mallinger J, Quinn M, Waterman M, Brooks B, et al. Vitality, mental health and satisfaction with information after breast cancer. Patient Educ Couns. 2007;66:58–66.CrossRefPubMed Griggs J, Sorbero M, Mallinger J, Quinn M, Waterman M, Brooks B, et al. Vitality, mental health and satisfaction with information after breast cancer. Patient Educ Couns. 2007;66:58–66.CrossRefPubMed
60.
Zurück zum Zitat Mao J, Bowman M, Stricker CT, DeMichele A, Jacobs L, Chan D, et al. Delivery of survivorship care by primary care physicians: the perspective of breast cancer patients. J Clin Oncol. 2009;27:933–8.CrossRefPubMed Mao J, Bowman M, Stricker CT, DeMichele A, Jacobs L, Chan D, et al. Delivery of survivorship care by primary care physicians: the perspective of breast cancer patients. J Clin Oncol. 2009;27:933–8.CrossRefPubMed
61.
Zurück zum Zitat Kantsniper M, McDonald E, Geller G, Shockney L, Snyder C, Wolff A. Transitioning to breast cancer survivorship: perspectives of patients, cancer specialists, and primary care providers. J Gen Intern Med. 2009;24 suppl 2:S459–66.CrossRef Kantsniper M, McDonald E, Geller G, Shockney L, Snyder C, Wolff A. Transitioning to breast cancer survivorship: perspectives of patients, cancer specialists, and primary care providers. J Gen Intern Med. 2009;24 suppl 2:S459–66.CrossRef
62.
Zurück zum Zitat Burg M, Lopez E, Dailey A, Keller M, Pendergrast B. The potential of survivorship care plans in primary care follow-up of minority breast cancer patients. J Gen Intern Med. 2009;24 suppl 2:S467–71.CrossRefPubMed Burg M, Lopez E, Dailey A, Keller M, Pendergrast B. The potential of survivorship care plans in primary care follow-up of minority breast cancer patients. J Gen Intern Med. 2009;24 suppl 2:S467–71.CrossRefPubMed
63.
Zurück zum Zitat Hurria A, Naylor M, Cohen HJ. Improving the quality of cancer care in an aging population: recommendations from an IOM report. JAMA. 2013;310:1795–6.CrossRefPubMed Hurria A, Naylor M, Cohen HJ. Improving the quality of cancer care in an aging population: recommendations from an IOM report. JAMA. 2013;310:1795–6.CrossRefPubMed
Metadaten
Titel
Associations among survivorship care plans, experiences of survivorship care, and functioning in older breast cancer survivors: CALGB/Alliance 369901
verfasst von
Leigh Anne Faul
Gheorghe Luta
Vanessa Sheppard
Claudine Isaacs
Harvey J. Cohen
Hyman B. Muss
Rachel Yung
Jonathan D. Clapp
Eric Winer
Clifford Hudis
Michelle Tallarico
Julhy Wang
William T. Barry
Jeanne S. Mandelblatt
Publikationsdatum
01.12.2014
Verlag
Springer US
Erschienen in
Journal of Cancer Survivorship / Ausgabe 4/2014
Print ISSN: 1932-2259
Elektronische ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-014-0371-5

Weitere Artikel der Ausgabe 4/2014

Journal of Cancer Survivorship 4/2014 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.